Noradrenergic and specific serotonergic antidepressant

Class of antidepressants

Overview

Chemical structure of mirtazapine

Noradrenergic and specific serotonergic antidepressants (NaSSAs) are a class of antidepressant drugs that are primarily used in the treatment of major depressive disorder (MDD). NaSSAs are known for their unique mechanism of action, which involves modulating the activity of both norepinephrine and serotonin neurotransmitters in the brain. This dual action is thought to contribute to their efficacy in alleviating depressive symptoms.

Mechanism of Action

NaSSAs work by antagonizing specific serotonin receptors (such as 5-HT2 and 5-HT3) and alpha-2 adrenergic receptors. By blocking these receptors, NaSSAs increase the release of norepinephrine and serotonin, enhancing neurotransmission in pathways that are often underactive in depression. This mechanism is distinct from that of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), which primarily inhibit the reuptake of serotonin and norepinephrine.

Clinical Use

NaSSAs are primarily prescribed for the treatment of major depressive disorder, particularly in patients who may not respond well to other classes of antidepressants. They are also sometimes used off-label for conditions such as anxiety disorders, insomnia, and post-traumatic stress disorder (PTSD).

Side Effects

Common side effects of NaSSAs include sedation, increased appetite, and weight gain. These effects are largely due to the antihistaminergic properties of the drugs. Unlike SSRIs and SNRIs, NaSSAs are less likely to cause sexual dysfunction, which can be a significant advantage for some patients.

Examples

The most well-known NaSSA is mirtazapine, which is widely used in clinical practice. Mirtazapine is often chosen for its sedative properties, which can be beneficial for patients with insomnia associated with depression.

Pharmacokinetics

NaSSAs are typically administered orally and have a relatively long half-life, allowing for once-daily dosing. They are metabolized in the liver and excreted primarily through the kidneys.

Related Pages

• Antidepressant
• Major depressive disorder
• Serotonin
• Norepinephrine
• Selective serotonin reuptake inhibitor
• Serotonin-norepinephrine reuptake inhibitor